Skip to main content

Table 1 Expression of APMCF1 in normal and malignant human tissues

From: Subcellular localization of APMCF1 and its biological significance of expression pattern in normal and malignant human tissues

Tissue type

Sample size

Score

Liver

  

   carcinoma tissues

2

+++/+++

   tumor-adjacent tissues

2

++/++

   normal tissues

2

++/+

Lung

  

   carcinoma tissues

2

+++/+++

   tumor-adjacent tissues

2

+/+

   normal tissues

2

+/+

Breast

  

   carcinoma tissues

2

++/+++

   tumor-adjacent tissues

2

++/+

   normal tissues

2

+/-

Stomach

  

   carcinoma tissues

2

++/++

   tumor-adjacent tissues

2

+/-

   normal tissues

2

-/-

Colon

  

   carcinoma tissues

2

+++/+++

   tumor-adjacent tissues

2

+/+

   normal tissues

2

++/-

Ovary

  

   carcinoma tissues

2

-/-

   tumor-adjacent tissues

2

-/-

   normal tissues

2

-/-

Esophagus

  

   carcinoma tissues

2

+++/+++

   tumor-adjacent tissues

2

++/+++

   normal tissues

2

+/+

Brain

  

   glioma tissues

2

-/-

   tumor-adjacent tissues

2

+/-

   normal tissues

2

+/+

Testis

  

   seminoma tissues

2

++/+

   tumor-adjacent tissues

2

+/-

   normal tissues

2

+/-

  1. As indicated in the Methods section, APMCF1 immunolabeling was scored as follows: weak immunolabeling (+), moderate immunolabeling (++), strong immunolabeling (+++), and no immunolabeling (-).
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us